Abstract
Align Technology will report fiscal second-quarter results on July 29, 2026 Post-Mkt; our preview synthesizes market forecasts, last quarter’s execution, and consensus drivers for revenue, margins, and EPS.
Market Forecast
Based on the company’s latest guidance set in the prior report and market tracking, consensus implies current-quarter revenue of 1.05 billion US dollars, down 0.61% year over year, with EBIT estimated at 225.48 million US dollars and EPS at 2.61, implying 1.76% YoY growth. Forecast models point to a modest YoY expansion in adjusted EPS despite a slightly lower top line, suggesting mix and cost control; year-over-year EBIT guidance implies a 1.43% decline. The main business is expected to remain resilient with stable performance in clear aligners and scanners; the aligner franchise continues to be the most promising segment with approximately 856.02 million US dollars last quarter and a constructive YoY trajectory.
Last Quarter Review
The previous quarter delivered revenue of 1.04 billion US dollars, a gross profit margin of 69.69%, GAAP net profit attributable to shareholders of 113.00 million US dollars, a net margin of 10.84%, and adjusted EPS of 2.58, up 21.13% year over year. An important highlight was EBIT of 223.82 million US dollars, up 19.87% YoY, while the main business breakdown featured clear aligners at 856.02 million US dollars and scanners at 184.06 million US dollars, reflecting the core revenue mix and stable demand dynamics.
Current Quarter Outlook
Main business: clear aligners
Clear aligners remain the core revenue engine this quarter, supported by an installed base of orthodontists and general practitioners and continued case starts. Forecast revenue softness versus last year is modest and appears tied to timing effects and regional variability rather than a structural shift. A flatter top line paired with sustained gross margin near last quarter’s level would still produce incremental operating leverage if case complexity and price/mix hold, which underpins the slight YoY EPS growth implied by forecasts.
Most promising business: clear aligners within premium and adult segments
Within clear aligners, premium case types and adult demand with higher average selling prices have potential to offset unit variability. If the mix skews toward comprehensive and teen packages with value-added digital treatment planning, revenue-per-case could support margin resilience. Execution on targeted marketing and conversion within dental service organizations would be key catalysts, particularly in North America, while new product iterations and software integrations can enhance case acceptance rates.
Key stock-price swing factors this quarter
Management commentary on case starts, regional momentum, and pricing discipline will drive sentiment given the slight YoY revenue dip in consensus. Investors will scrutinize gross margin sustainability around the high-60s level and whether cost optimization can shield EBIT from top-line pressure. Update on scanner attach rates and digital workflow adoption may influence multi-quarter growth expectations, as higher intraoral scanner penetration often leads to increased aligner utilization over time.
Analyst Opinions
Cumulative analyst commentary over the last six months skews cautiously positive. Several well-followed institutions emphasize stable demand trends and margin discipline, expecting EPS to edge higher year over year even if revenue is flat to slightly down. The bullish camp, forming the majority of recent notes, points to resilient aligner mix, potential upside from scanner-driven workflow adoption, and disciplined operating expense control that can preserve earnings quality this quarter.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments